214 related articles for article (PubMed ID: 12399202)
1. CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein.
Gschoesser C; Almanzar G; Hainz U; Ortin J; Schonitzer D; Schild H; Saurwein-Teissl M; Grubeck-Loebenstein B
Vaccine; 2002 Nov; 20(31-32):3731-8. PubMed ID: 12399202
[TBL] [Abstract][Full Text] [Related]
2. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
3. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
[TBL] [Abstract][Full Text] [Related]
5. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
7. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.
Ulmer JB; Fu TM; Deck RR; Friedman A; Guan L; DeWitt C; Liu X; Wang S; Liu MA; Donnelly JJ; Caulfield MJ
J Virol; 1998 Jul; 72(7):5648-53. PubMed ID: 9621023
[TBL] [Abstract][Full Text] [Related]
8. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
9. Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.
Grant E; Wu C; Chan KF; Eckle S; Bharadwaj M; Zou QM; Kedzierska K; Chen W
Immunol Cell Biol; 2013 Feb; 91(2):184-94. PubMed ID: 23399741
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
Oran AE; Robinson HL
J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
[TBL] [Abstract][Full Text] [Related]
12. Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection.
Po JL; Gardner EM; Anaraki F; Katsikis PD; Murasko DM
Mech Ageing Dev; 2002 Apr; 123(8):1167-81. PubMed ID: 12044966
[TBL] [Abstract][Full Text] [Related]
13. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
Freer G; Senesi S
Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
[TBL] [Abstract][Full Text] [Related]
14. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses.
Tite JP; Russell SM; Dougan G; O'Callaghan D; Jones I; Brownlee G; Liew FY
J Immunol; 1988 Dec; 141(11):3980-7. PubMed ID: 3263440
[TBL] [Abstract][Full Text] [Related]
15. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
[TBL] [Abstract][Full Text] [Related]
16. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Boon AC; de Mutsert G; van Baarle D; Smith DJ; Lapedes AS; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Immunol; 2004 Feb; 172(4):2453-60. PubMed ID: 14764717
[TBL] [Abstract][Full Text] [Related]
17. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
[TBL] [Abstract][Full Text] [Related]
18. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
19. Human T cell recognition of influenza A nucleoprotein. Specificity and genetic restriction of immunodominant T helper cell epitopes.
Brett SJ; Blau J; Hughes-Jenkins CM; Rhodes J; Liew FY; Tite JP
J Immunol; 1991 Aug; 147(3):984-91. PubMed ID: 1713610
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antigen-specific activation of CD8+ memory cytotoxic T cells by B cell-derived factors.
Kos FJ; Müllbacher A
Immunobiology; 1992 Nov; 186(5):410-20. PubMed ID: 1286880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
